BSEVipul Organics Ltd· Chemicals & PetrochemicalsHighNeutral
Announced Fri, 13 Feb, 2026 · 13:28 IST

Unaudited Standalone and consolidated financial result of the company for the quarter & nine months ended December 31,2025

Pat Growth 25pctEbitda Margin ExpansionResults View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-0.9%Reaction day
₹214.95
prior close
₹213.05
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-1.5%+0.6% vs market
Specialty Chemicals peers, median of 86sector-1.6%+0.7% vs sector

On the reaction day the stock moved 0.6 pts more than Nifty Microcap 250 and 0.7 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+1.4
10m
+1.4
15m
-1.0
30m
-1.0
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-0.9-1.5+0.6-1.6+0.7
Next day
-0.4-2.2+1.7-3.0+2.5
2d
-1.5-1.2-0.3-2.5+1.0
3d
-1.8-0.9-0.9-1.6-0.3
4d
-4.4-2.3-2.0-2.9-1.5
5d
-2.0-2.5+0.5-3.0+1.1
1w
-5.7-3.6-2.2-3.5-2.3
15d
-12.5-10.4-2.1-10.3-2.3
1m
-21.4-11.3-10.1-11.0-10.3
2m
-13.0-3.6-9.5-5.5-7.5
3m
-7.0+3.9-10.8+1.3-8.3
UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 86Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Vipul Organics Ltd reported revenue from operations of Rs. 4,614.01 lakhs for Q3 FY26, up 11.4% from Rs. 4,141.24 lakhs in Q3 FY25. For 9M FY26, revenue rose to Rs. 12,317.44 lakhs from Rs. 11,871.26 lakhs, a modest 3.8% increase. Profit after tax grew much faster — Q3 PAT jumped 27.9% to Rs. 185.55 lakhs, while 9M PAT climbed 35.2% to Rs. 493.76 lakhs, reflecting improved operating efficiency. EPS for 9M FY26 stood at Rs. 2.92 versus Rs. 2.26 last year. The statutory auditor (J.A. Rajani & Co.) issued an unqualified limited review report on both standalone and consolidated results. During the quarter, the company also allotted 13.05 lakh equity shares at Rs. 211 each via preferential issue, raising Rs. 27.54 crore (reduced from originally approved Rs. 35.24 crore), with proceeds yet to be utilised and parked in fixed deposits.

Likely market impact

Strong PAT growth despite tepid revenue indicates margin expansion and cost discipline, which is positive for shareholders. The new equity infusion strengthens the balance sheet for capacity expansion and debt reduction, though near-term EPS will be slightly diluted due to the larger share base.